Amedica decreases range to $8 to $10 and increases shares offered

By Renaissance Capital,

Shutterstock photo

Amedica, which develops and sells medical devices using its silicon nitride technology platform, lowered the proposed deal size for its upcoming IPO on Wednesday. The Salt Lake City, UT-based company now plans to raise $32 million by offering 3.5 million shares at a price range of $8 to $10. The company had previously filed to offer 3.2 million shares at a range of $10 to $12. At the low end of the revised range, Amedica would raise 20% fewer proceeds than previously anticipated.

Amedica, which was founded in 1996 and booked $23 million in sales for the 12 months ended September 30, 2013, plans to list on the NASDAQ under the symbol AMDA. Amedica initially filed confidentially on September 23, 2013. JMP Securities is the sole bookrunner on the deal. It is expected to price during the week of February 10, 2014.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines IPOs
Referenced Stocks: AMDA

More from Renaissance Capital


Renaissance Capital

Renaissance Capital

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by